DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025

DexCom, Inc. (NASDAQ:DXCM) is one of the Best Fundamental Stocks to Buy According to Analysts. On January 12, the company released its preliminary, unaudited results for Q4 2025, with total revenue coming at ~$1.260 billion, reflecting an increase of 13% YoY. Notably, the US revenue is projected to be ~$892 million, demonstrating 11% growth compared to Q4 2024. DexCom (DXCM) Releases Preliminary, Unaudited Results for Q4 2025 DexCom, Inc. (NASDAQ:DXCM) ended 2025 on a healthy note, with revenue surpassin ...